Adverum Biotechnologies, Inc. ADVM

Full chart Compare
Set alert

Price alert · ADVM

All alert types
4.36 USD 0.00 (+0.00%)

At closeDec 9, 2025, 4:00 PM EST

4.49 +0.13 +2.98%

After hours · Dec 9, 4:00 PM ET

4.24 Day range 4.36

52-week range unavailable

YTD
-6.64%
1 year
-26.23%

Revenue & Expenses

Other Income → Expenses: $8.23MExpenses → Selling, General & Admin: $63.12MExpenses → Research & Development: $77.04MGross Profit → Expenses: $1.00MRevenue → Gross Profit: $1.00MNet Loss → Expenses: $130.93MOther Income$8.23MGross Profit$1.00MNet Loss$130.93MExpenses$140.16MSelling, General & Admin$63.12MResearch & Development$77.04MRevenue$1.00M

Latest period ending Dec 31, 2024 · select a line to chart its full history

ADVM annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
1.00M3.60M07.50M0
1.00M3.60M07.50M0
-139.16M-128.94M-157.13M-146.12M-117.95M
-130.93M-122.12M-154.54M-145.54M-117.51M
-6.62-12.11-15.60-14.80-13.80
ADVM annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
62.63M76.98M70.93M36.70M63.42M
179.84M155.77M308.37M439.73M482.57M
109.13M88.55M126.85M123.54M48.22M
86.04M68.56M93.56M101.11M26.23M
70.71M67.22M181.52M316.19M434.35M
ADVM annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-92.46M-90.90M-108.09M-107.83M-79.29M
-41.89M96.88M141.72M78.71M-280.17M
120.00M69.00K607.00K2.40M355.99M
-388.00K-808.00K-11.82M-15.12M-11.84M
-14.35M6.04M34.24M-26.73M-3.47M